Affiliation:
1. Independent Researcher
2. Don Bosco Senior Secondary School, Jharmari, Punjab
Abstract
Recent studies have shown that the progression of SARS-CoV-2 is associated with human genetic factors. Many patients have shown diverse clinical symptoms based on their age, sex, ABO blood type, underlying medical conditions, HLA system, and viral variants found in their samples. SARS-CoV-2 is considered more transmissible with higher morbidity rates as compared to the previous SARS outbreak. Several case studies have supported the direct relation of cardiovascular and pulmonary fatalities related to ACE2 polymorphisms during COVID-19 infection. SARS-CoV-2 mutants and human genome polymorphisms are vital predictive markers in finding a cure for this pandemic. This review focuses on some of the critical genetic factors of the host that affect the array of immunological responses as a result of COVID-19 infection among individuals.
Publisher
The Applied Biology & Chemistry Journal
Reference76 articles.
1. [1] Virus taxonomy: 2019 release; International Committee on Taxonomy of Viruses - The International Code of Virus Classification and Nomenclature (2019). https://talk.ictvonline.org/taxonomy/ (accessed 15 September 2020).
2. [2] de Groot RJ, Baker SC, Baric RS, Brown CS, Drosten C, Enjuanes L, et al (2013). Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group. J Virol.; 87(14):7790–7792.
3. [3] van der Hoek L (2007). Human coronaviruses: what do they cause? Antivir Ther;12(4B):651–658.
4. [4] Chen B, Tian EK, He B, Tian L, Han R, Wang S, et al (2020). Overview of lethal human coronaviruses. Signal Transduct Target Ther; 5:89. https://doi.org/10.1038/s41392-020-0190-2
5. [5] Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al (2020). A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med; 382(8):727-733.